Humanwell Healthcare (600079.SH): Major shareholder filed for restructuring by creditors.
Renfu Medicine (600079.SH) announcement, the company received on September 24, 2024, from the controlling shareholder Wuhan Contemporary...
Humanwell Healthcare (600079.SH) announced that on September 24, 2024, the company received a notice letter from its controlling shareholder, Wuhan Contemporary Technology Industry Group Co., Ltd. ("Contemporary Technology"), regarding an application for reorganization. The company learned that Wuhan Credit Risk Management Financing Guarantee Co., Ltd. and Tianjin Shengzha Law Firm (hereinafter referred to as the "applicants") have applied to the Wuhan Intermediate People's Court in Hubei Province ("Wuhan Court" or "Court") for the reorganization of Contemporary Technology.
Related Articles

New Stock Outlook | With the support of more than ten state-owned shareholders, can the merger and acquisition growth story of Tiandi HeXing earn market approval?

Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
New Stock Outlook | With the support of more than ten state-owned shareholders, can the merger and acquisition growth story of Tiandi HeXing earn market approval?

Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


